¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Ä¥°î°æºÏ´ëÇб³º´¿ø The 1st International Symposium on Precision Oncology in Breast Cancer : 2024-05-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Ä¥°î°æºÏ´ëÇб³º´¿ø The 1st International Symposium on Precision Oncology in Breast Cancer : 2024-05-25
±³À°ÀÏÀÚ : 2024-05-25
±³À°Àå¼Ò : Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°­´ç

±³À°ÁÖÁ¦ : The 1st International Symposium on Precision Oncology in Breast Cancer

ÁÖÃÖ±â°ü : Ä¥°î°æºÏ´ëÇб³º´¿ø
´ã´çÀÚ : °­º´ÁÖ
¿¬¶ôó : 053-200-7281  

À̸ÞÀÏ : knuh_bts@naver.com

±³À°Á¾·ù : ³»°ú, ¿Ü°ú

Âü¼®¿¹»óÀÎ : 50¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 5 ½Ã°£ 10ºÐ

¼¼ºÎ¼ö°­·á : 10,000¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 09:30~09:40 Opening remark ( )

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 09:30~10:00 Aquaporin water channels as regulators of cell-cell adhesion proteins Tae-Hwan Kwon(Dean. School of Medicine Kyungpook National University)

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 10:10~10:40 Multimodal chemo-, gene, and immunotherapy for cancer Young Jik Kwon(University of California, Irvine)

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 10:40~11:10 Next-generation diagnostic technology for breast cancer detection and treatment monitoring Hyungsoon Im(Harvard Medical School)

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 11:10~11:40 Towards the precision oncology through innovative clinical trials and translational efforts Young Kwang Chae(Northwestern University)

Åä·Ð 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 11:40~11:50 Q & A ()

½Ä»ç 05¿ù 25ÀÏ 11:50~13:00 Lunch ()

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 13:00~13:20 Prediction of neoadjuvant chemotherapy response using ctDNA in HER2+ breast cancer Soo Jung Lee(Kyungpook National University)

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 13:20~13:40 Deep Learning-based Radiogenomic Prediction Study for Combined Breast MRI and OncotypeDX Recurrence Scores in Breast Cancer: A Fully-Automated Framework Jeeyeon Lee(Kyungpook National University)

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 13:40~14:00 Testing for ESR1 mutations in the ctDNA from ER+/HER2- advanced or metastatic breast cancer Sung-hye Hong(Gencurix Inc.)

Åä·Ð 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 14:00~14:10 Q & A ()

ÈÞ½Ä 05¿ù 25ÀÏ 14:10~14:20 Coffee Break ()

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 14:20~14:35 Prediction of pCR in hormone positive breast cancer In Hee Lee(Kyungpook National University)

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 14:35~14:50 Molecular tuned extracellular blebs for improved vaccination and intracellular delivery Olivia Ritchie(University of California, Irvine)

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 14:50~15:05 Multimodal gene delivery platform for versatile combination cancer therapies Rebecca Lee(University of California, Irvine)

Åä·Ð 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 15:05~15:15 Q & A ()

ÈÞ½Ä 05¿ù 25ÀÏ 15:15~15:25 Coffee Break ()

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 15:25~15:40 LncRNA in breast cancer: SOX2OT and IGF2-AS in tamoxifen-resistant cell lines Byeongju Kang(Kyungpook National University)

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 15:40~15:55 Transplant-Oncology, a new era of innovation for the select cancer patients; DREAM registration study Chan Mi Jung(Northwestern University)

±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 15:55~16:10 Development of Chimeric Antigen Receptor (CAR) Based NK Cell Immunotherapy Against Solid Tumor Jee Young Chung(CHA Advanced Research Institute)

Åä·Ð 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 16:10~16:20 Q & A ()

±âŸ 05¿ù 25ÀÏ ´ë°­´ç(1µ¿ÁöÇÏ1Ãþ) 16:20~16:30 Closing remark ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Ä¥°î°æºÏ´ëÇб³º´¿ø The 1st International Symposium on Precision Oncology in Breast Cancer : 2024-05-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-25
´ÙÀ½±Û (¿Â¶óÀÎ)2024³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦1Â÷ FLS ÄÚµð³×ÀÌÅÍ ¿öÅ©¼ó : 2024-05-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
392 ÃæºÏ ÃæºÏ´ëÇб³º´¿ø 2018³â Á¦ 5ȸ ´ëÀüÃæû Á·ºÎÁ·°üÀý ½ÉÆ÷Áö¾ö : 2018-09-02 0 998 2018-08-15
391 ¼­¿ï Preterm Birth International Collaborative Australasian(´ëÇÑ»êºÎÀΰúÇÐȸ&¼¼°èÁ¶»êÇÐȸ °øµ¿ÁÖ°ü) : 2018-09-01 0 779 2018-08-15
390 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø 2018³â ¾ÆÁÖ´ëÇб³ ¸¶ÃëÅëÁõÀÇÇаú Ãß°è Çмú´ëȸ : 2018-09-01 0 1,248 2018-08-15
389 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7Â÷ International Congress on Lipid Metabolism & Atherosclerosis (ICoLA 2018) : 2018-09-01 0 583 2018-08-15
388 °æ³² â¿ø°æ»ó´ëÇб³º´¿ø 2018³â Áߺΰ泲 ¿¬¼ö±³À° : 2018-09-01 0 935 2018-08-15
387 °­¿ø Á¦19ȸ ´ëÇÑ Ã´Ãß¿Ü°úÇÐȸ ôÃßÅëÁõ¿¬±¸È¸ ½ÉÆ÷Áö¿ò : 2018-09-01 0 873 2018-08-15
386 ºÎ»ê Á¦15ȸºÎ¿ï°æÇǺΰúÀÇ»çȸÇмú´ëȸ : 2018-09-01 0 1,080 2018-08-15
385 ¼­¿ï 2018 ¼­¿ï¾Æ»êº´¿ø À̺ñÀÎÈÄ°ú Ãß°è ÀÓ»ó ¿öÅ©¼¥ : 2018-09-01 0 767 2018-08-15
384 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ Á¤Çü¿Ü°úÁúȯ, ¼Õ»ó, Ä¡·á : 2018-09-01 0 1,475 2018-08-15
383 ¼­¿ï Preterm Birth International Collaborative Australasian(´ëÇÑ»êºÎÀΰúÇÐȸ&¼¼°èÁ¶»êÇÐȸ °øµ¿ÁÖ°ü) : 2018-08-31 0 1,138 2018-08-15
382 ¼­¿ï Çѱ¹Á÷¹«½ºÆ®·¹½ºÇÐȸ 2018³â ÇÏ°èÇмú´ëȸ : 2018-08-31 0 563 2018-08-15
381 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7Â÷ International Congress on Lipid Metabolism & Atherosclerosis (ICoLA 2018) : 2018-08-31 0 605 2018-08-15
380 ºÎ»ê ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ºÎ»êÁöºÎÇÐȸ 8¿ù ¿ù·ÊÁý´ãȸ : 2018-08-30 0 1,257 2018-08-15
379 °­¿ø ¿øÁÖ ¼¼ºê¶õ½º ±âµ¶º´¿ø ±âÃʾȰúÁúȯ / CÇü °£¿° : 2018-08-29 0 2,249 2018-08-15
378 ¼­¿ï ´ëÇѼҾư¨¿°ÇÐȸ Á¦154Â÷ ¿ù·Ê¿¬¼ö°­ÁÂ(°¨¿°°ü¸® ¿¬¼ö±³À°) : 2018-08-28 0 633 2018-08-15
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷